波司登(03998.HK)除淨日跌逾6% 本周初斥逾3,100元回購
波司登(03998.HK)於本周一及周二共斥逾3,100萬元回購1,000萬股,但該股反覆兩連跌,今日中期股息3仙除淨,早市高開見3.16元遇阻,掉頭跌破10天線(3.08元),最低見2.88元,現造2.9元,續跌6.1%,成交7,068萬股,涉資2.1億元。
波司登公布,已根據股東於8月26日通過決議案,公司董事獲授一般授權購回股份,數目不超過8月26日已發行股份總數10%。公司剛於本周二、三(月23日及24日)以每股介乎2.95-3.23元,先後各回購500萬股,共涉資3,104.8萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.